Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126057 · ClinicalTrials.gov registry record · NA
Myopia Assessment of Two Manufacturing Processes
A NA study of Juvenile Myopia, sponsored by SightGlass Vision.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 5
- Study locations
NCT04126057: Completed NA study of Juvenile Myopia, sponsored by SightGlass Vision.
NCT04126057 is a NA study of Juvenile Myopia that has completed, run by SightGlass Vision. The registered enrollment target is 50 participants, below the 130-participant average among 6 other Juvenile Myopia trials with a reported enrollment target (62% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04126057, a NA study of Juvenile Myopia, has completed, sponsored by SightGlass Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 5
- Study locations
Study Summary
Randomized, controlled, multisite, subject- and observer-masked, contralateral clinical trial of 6-month duration to compare two SightGlass Vision Diffusion Optics Technology (DOT) spectacle lens manufacturing processes in reducing the progression of juvenile myopia.
Primary Outcome
Change in axial length progression over time between DOT spectacle lenses manufactured by method A versus method B Axial length progression is defined as an axial length elongation that is attributable to myopia.
Conditions Studied
Interventions
- DEVICE SightGlass Vision DOT Spectacle Lenses
Study Locations (5)
Florida
- Sabal Eye Care - Longwood
Kansas
- Kannarr Eye Care - Pittsburg
Missouri
- Advanced Eyecare PC - Raytown
New York
- SUNY School of Optometry - New York
Utah
- William J Bogus, OD, FAAO - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2020-09-16 |
| Phase | NA |
What the finished NCT04126057 record still lists
NCT04126057 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 130-participant average among 6 other Juvenile Myopia trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Juvenile Myopia appearing as the primary indexed condition, and to 1 intervention - of which SightGlass Vision DOT Spectacle Lenses is the first listed.
NCT04126057 lists 5 locations in 5 states (Florida, Kansas, Missouri).
Frequently Asked Questions
What is clinical trial NCT04126057 about?
NCT04126057 is a clinical study titled "Myopia Assessment of Two Manufacturing Processes". Randomized, controlled, multisite, subject- and observer-masked, contralateral clinical trial of 6-month duration to compare two SightGlass Vision Diffusion Optics Technology (DOT) spectacle lens manufacturing processes in reducing the progression of juvenile myopia.
What is the current status of trial NCT04126057?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2019-12-02. Estimated completion is 2020-09-16.
What conditions does trial NCT04126057 study?
This clinical trial studies the following conditions: Juvenile Myopia.
What interventions are being tested in trial NCT04126057?
The interventions under investigation include: SightGlass Vision DOT Spectacle Lenses (DEVICE).
Who is sponsoring clinical trial NCT04126057?
This trial is sponsored by SightGlass Vision, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04126057 being conducted?
This trial has 5 study locations across Florida, Kansas, Missouri, New York, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Juvenile Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Children's Viewing Behavior
RECRUITING · NA
-
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
RECRUITING · NA
-
CYPRESS Efficacy and Safety Study Extension
ACTIVE NOT RECRUITING · NA
-
Control of Myopia Using Novel Spectacle Lens Designs
ACTIVE NOT RECRUITING · NA
-
Myopia Control Spectacle Lens Cessation Study
ACTIVE NOT RECRUITING · NA
-
Spectacle Lens Visual Acuity Assessments Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI